| Bioactivity | Bardoxolone methyl (NSC 713200; RTA 402; CDDO Methyl ester) is a synthetic triterpenoid compound with potential antineoplastic and anti-inflammatory activities, acting as an activator of the Nrf2 pathway and an inhibitor of the NF-κB pathway. | ||||||||||||
| Name | Bardoxolone methyl | ||||||||||||
| CAS | 218600-53-4 | ||||||||||||
| Formula | C32H43NO4 | ||||||||||||
| Molar Mass | 505.69 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Bardoxolone methyl
CAS: 218600-53-4 F: C32H43NO4 W: 505.69
Bardoxolone methyl (NSC 713200; RTA 402; CDDO Methyl ester) is a synthetic triterpenoid compound with potential antineop
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.